Wilmington Savings Fund Society’s Moderna MRNA Stock Holding History

Wilmington Savings Fund Society’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.54K	Buy	+22	New	+$1.14K	﹤0.01%	1369
2025 Q3	–	Sell	-2,649	Closed	-$73.1K	–	1800
2025 Q2	$73.1K	Buy	2,649 +2,048	+341%	+$53.9K	﹤0.01%	1121
2025 Q1	$17K	Sell	601 -185	-24%	-$6.57K	﹤0.01%	1502
2024 Q4	$32.7K	Buy	786 +587	+295%	+$28.1K	﹤0.01%	1356
2024 Q3	$13.3K	Buy	+199	New	+$18.3K	﹤0.01%	1570

Other funds holding MRNA

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

TFCP

Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return

Wilmington Savings Fund Society's MRNA Position: Q2 2026 in Review

Wilmington Savings Fund Society opened a new position in Moderna (MRNA) in Q2 2026: 22 shares worth $1.54K. The stake represents ﹤0.01% of the portfolio and ranks #1369 among its holdings. This is a return to the name: Wilmington Savings Fund Society previously reported a position in MRNA as recently as Q2 2025.

Wilmington Savings Fund Society first reported a position in MRNA in Q3 2024 and has held it in 5 quarters since. The position peaked at $73.1K in Q2 2025. 283 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Wilmington Savings Fund Society held 22 shares of Moderna worth $1.54K as of Q2 2026.
Moderna was a new Wilmington Savings Fund Society position in Q2 2026.
Moderna made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1369 holding.
Wilmington Savings Fund Society first reported a position in Moderna in Q3 2024 and has held it in 5 quarters since.
Wilmington Savings Fund Society's Moderna position peaked at $73.1K in Q2 2025.
283 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.